ClinicalTrials.Veeva
Menu

Find clinical trials for Kidney Disease in Orlando, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Kidney Diseases
Chronic Renal Insufficiency
Chronic Kidney Failure
IGA Glomerulonephritis
Renal Insufficiency
Renal Cell Carcinoma
Kidney Cancer

Kidney Disease trials near Orlando, FL, USA:

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

This is purpose of this study is to evaluate the safety, tolerability, and effect on Albuminuria of MZE829 in Adults with APOL1 Kidney Disease...

Enrolling
Proteinuric Kidney Disease
Drug: MZE829

Phase 2

Maze Therapeutics

Orlando, Florida, United States and 87 other locations

purpose of the study is to evaluate the efficacy, safety, and tolerability of Inaxaplin (IXP) in participants with proteinuric APOL1- mediated kidney...

Active, not recruiting
Proteinuric Kidney Disease
Drug: Inaxaplin

Phase 2

Vertex Pharmaceuticals
Vertex Pharmaceuticals

Orlando, Florida, United States and 35 other locations

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney disease that caus...

Enrolling
Autosomal Dominant Polycystic Kidney Disease
Drug: ABBV-CLS-628
Drug: Placebo

Phase 2

AbbVie
AbbVie

Sanford, Florida, United States and 74 other locations

drugs"). The study is focused on participants who have diabetic kidney disease.The aim of the study is to see how safe and effectiv...

Enrolling
Diabetic Kidney Disease (DKD)
Drug: Evinacumab
Drug: ALN-ANG3 placebo

Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Port Orange, Florida, United States of America and 48 other locations

The purpose of this study is to assess the efficacy and safety of AZD2373 in participants diagnosed with APOL1-Mediated Kidney Disease...

Enrolling
APOL1-Mediated Kidney Disease
Combination Product: Placebo
Device: APOL1 Genotyping Clinical Trial Assay

Phase 2

AstraZeneca
AstraZeneca

Orlando, Florida, United States and 76 other locations

baxdrostat in combination with dapagliflozin compared with baxdrostat/placebo on albuminuria, as well as safety, in participants with chronic kidney...

Enrolling
Chronic Kidney Disease and Hypertension
Drug: Baxdrostat/dapagliflozin
Drug: Baxdrostat/Placebo

Phase 2

AstraZeneca
AstraZeneca

Port Orange, Florida, United States and 70 other locations

Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors ...

Enrolling
Kidney Failure, Chronic
Diabetic Nephropathies
Drug: Placebo
Drug: Sotagliflozin

Phase 3

Alessandro Doria

Orlando, Florida, United States and 18 other locations

tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...

Enrolling
Proteinuric Kidney Disease
Drug: VX-147
Drug: Placebo

Phase 2, Phase 3

Vertex Pharmaceuticals
Vertex Pharmaceuticals

Orlando, Florida, United States and 330 other locations

and pharmacokinetics of AZD1613 following subcutaneous or intravenous administration in participants with autosomal dominant polycystic kidney...

Enrolling
Autosomal Dominant Polycystic Kidney Disease
Drug: Placebo - Part B
Drug: Placebo - Part A

Phase 1

AstraZeneca
AstraZeneca

Orlando, Florida, United States and 14 other locations

This study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse. People who have taken a specific t ...

Active, not recruiting
Chronic Kidney Disease
Drug: Vicadrostat
Drug: Empagliflozin

Phase 2

Boehringer Ingelheim
Boehringer Ingelheim

Ocoee, Florida, United States and 158 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems